- List
- By Topic
- On Map
- Search Details

Deprenyl (16 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00535262 | Terminated Has Results |
A Pilot Study Assessing EmSam in Bipolar Depression |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
3 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00535262 | #5439 | March 2007 | February 2012 | February 2012 | September 26, 2007 | October 28, 2014 | October 28, 2014 |
|
||
2 | NCT00640159 | Completed | Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
55 | All | 30 Years to 90 Years (Adult, Older Adult) | NCT00640159 | H-20709 | January 2007 | June 2008 | August 2008 | March 21, 2008 | March 16, 2009 |
|
|||
3 | NCT00532116 | Completed | PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
32 | All | 18 Years and older (Adult, Older Adult) | NCT00532116 | S9303-P0601 | April 2007 | August 2007 | September 19, 2007 | September 19, 2007 |
|
||||
4 | NCT00531947 | Completed Has Results |
Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
308 | All | 12 Years to 17 Years (Child) | NCT00531947 | S9303-P0605 | July 2007 | October 2010 | October 2010 | September 19, 2007 | January 15, 2014 | June 26, 2013 |
|
||
5 | NCT00531596 | Completed | Evaluation of Adhesion and Dermal Tolerability of EMSAM |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
300 | All | 18 Years and older (Adult, Older Adult) | NCT00531596 | S9303-P0602 | April 2007 | July 2007 | September 19, 2007 | September 19, 2007 |
|
||||
6 | NCT00002154 | Completed | A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia |
|
|
Interventional |
Phase 2 |
|
Other |
|
32 | All | 18 Years and older (Adult, Older Adult) | NCT00002154 | 250A 03-D95 |
August 31, 2001 | June 24, 2005 |
|
|||||||
7 | NCT00218517 | Completed | Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1 |
|
|
Interventional |
Phase 2 |
|
NIH |
|
|
19 | All | 18 Years and older (Adult, Older Adult) | NCT00218517 | NIDA-19246-1 R21-19246-1 DPMC |
March 2005 | July 2007 | July 2007 | September 22, 2005 | January 12, 2017 |
|
|||
8 | NCT00443872 | Completed Has Results |
Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists |
|
|
Interventional |
Phase 4 |
|
Other / Industry |
|
|
77 | All | 30 Years to 90 Years (Adult, Older Adult) | NCT00443872 | VAL-1.0-IV | AtoZ | March 2007 | September 2008 | December 2008 | March 6, 2007 | October 31, 2014 | October 31, 2014 |
|
|
9 | NCT00027040 | Completed | A Study of Decreased Mental Function Associated With HIV |
|
|
Interventional |
Not Applicable |
|
NIH |
|
90 | All | 18 Years and older (Adult, Older Adult) | NCT00027040 | A5114s AACTG A5114s ACTG A5114s |
June 2005 | November 19, 2001 | January 16, 2015 |
|
||||||
10 | NCT00013585 | Completed | Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients |
|
|
Interventional |
Phase 2 |
|
NIH / Other |
|
|
127 | All | 18 Years and older (Adult, Older Adult) | NCT00013585 | A5090 10075 ACTG A5090 AACTG A5090 |
December 2005 | August 31, 2001 | May 21, 2012 |
|
|||||
11 | NCT00129311 | Completed Has Results |
Usefulness of Selegiline as an Aid to Quit Smoking - 1 |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
101 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00129311 | NIDA-15757-1 R01DA015757 R01-15757-1 DPMC |
July 2004 | December 2012 | December 2012 | August 11, 2005 | March 31, 2015 | July 16, 2014 |
|
||
12 | NCT01701089 | Completed | A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
17 | All | 50 Years to 80 Years (Adult, Older Adult) | NCT01701089 | BP28253 | September 2012 | May 2013 | May 2013 | October 4, 2012 | November 2, 2016 |
|
|||
13 | NCT01912391 | Completed | Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
30 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01912391 | PJM-01 WV26504-4245 |
October 2012 | March 2015 | March 2015 | July 31, 2013 | October 8, 2015 |
|
|||
14 | NCT01330030 | Completed Has Results |
Selegiline Patch for Treatment of Nicotine Dependence |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
243 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01330030 | SU-07232007-459 R01DA017457 |
July 2005 | August 2008 | July 2011 | April 6, 2011 | August 10, 2016 | April 4, 2016 |
|
||
15 | NCT02225548 | Recruiting | Sagene 2014 - Parkinson's Disease and Erectile Dysfunction |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
10 | Male | 40 Years to 64 Years (Adult) | NCT02225548 | Sagene 2014 | September 2014 | December 2018 | January 2019 | August 26, 2014 | December 20, 2017 |
|
|||
16 | NCT01495195 | Completed | Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
12 | All | 21 Years to 50 Years (Adult) | NCT01495195 | R21DA029787 | SDC | February 2012 | May 2013 | May 2013 | December 19, 2011 | December 18, 2013 |
|
† Study has passed its completion date and status has not been verified in more than two years.